跳转到主要内容

Join us in celebrating Rare Disease Day 2021!

Developing treatments for rare diseases is a complex process. We’re committed to helping biotech and pharma fulfill the unmet needs that often accompany diseases affecting fewer than 1 in 2000 people.

Rare disease trials require special considerations for overall regulatory strategy, patient recruitment, data navigation, and market access to name a just few.  Certara’s experts use cutting edge biosimulation and regulatory science to help our partners get these critical medicines into the hands of patients who need them.


Check out these resources illustrating our extensive impact on Rare Disease Programs:

罕见病和孤儿药开发

Making Sense of 6MWT Variability: Developing a Disease Progression Model for DMD

如何加快 FDA 对孤儿药的审批

罕见病药物困境:价值大、价格高、准入受限?

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software